Home › Amgen: Its biosimilar version of Humira about as effective
 

Keywords :   


Amgen: Its biosimilar version of Humira about as effective

2015-02-04 00:09:02| Biotech - Topix.net

Biologic drugmaker Amgen says its biosimilar version of rheumatoid arthritis drug Humira worked similarly in a key head-to-head test. Amgen Inc. says its ABP 501 produced similar results in the percentage of patients in the 26-week, late-stage study who saw improvements in pain, ability to function and number of swollen and tender joints.

Tags: version effective amgen humira

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
03.07Hurricane Beryl Public Advisory Number 17A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07How Microsoft and Nvidia bet correctly to leapfrog Apple
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
03.07Keep livestock safe during hurricane season with an emergency plan
More »